CIDRAP News: Market-entry rewards seen as good option for getting new antibiotics
“A system in which drug companies would win sizable government payments for bringing new antibacterial drugs to market may be the best of various possible ways to encourage the development of such products by boosting their profitability, according to a new report from the Transatlantic Task Force on Antimicrobial Resistance (TATFAR). The report, published [Wednesday] in Clinical Infectious Diseases, looks at six ‘pull’ incentives for promoting the development of new antibacterial drugs in the face of rising antimicrobial resistance worldwide…” (Roos, 6/8).